fentaNYL Citrate — Class II drug recall D-0548-2026
Ongoing recall by IntegraDose Compounding Services LLC, reported 2026-05-27, distributed nationwide. Subpotent Drug
| Recall number | D-0548-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | IntegraDose Compounding Services LLC, Shoreview, MN, United States |
| Recall initiated | 2026-05-12 |
| Classified | 2026-05-21 |
| Reported by FDA | 2026-05-27 |
| Distributed | Nationwide (US) |
| Quantity | 376 cassettes |
| Reason classes | potency |
| NDC | 71139-6030-01 |
| Lot numbers | 20260310FEN-1 |
| Expiration dates | 2026-09-06 |
Product
fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose Compounding Services LLC, 3650 Victorie St N, Suite 900, Shoreview, MN, NDC 71139-6030-1.
Reason for recall
Subpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0548-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.